Emergent BioSolutions Inc (NYSE:EBS)

53.63
Delayed Data
As of Jun 20
 -0.21 / -0.39%
Today’s Change
31.38
Today|||52-Week Range
55.94
+15.41%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2017
Quarter 3
2017
Quarter 4
2017
Quarter 1
2018
Revenue and IncomeNet Revenues100.8M149.4M193.8M117.8M
 
 
 
 
 
Cost of Goods Sold24.5M33.8M51.1M44.7M
 
 
 
 
 
Depreciation And Amortization9.9M9.8M12.7M12.4M
 
 
 
 
 
 
Operating ExpensesGross Income66.4M105.8M130.0M60.8M
 
 
 
 
 
General Expenses57.6M57.2M70.5M69.3M
 
 
 
 
 
Research And Development25.8M22.7M28.5M29.1M
 
 
 
 
 
Total Operating Expenses92.0M100.7M134.3M126.3M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income8.8M48.7M59.6M-8.5M
 
 
 
 
 
Extraordinary Charge-253.0K-917.0K-6.5M-989.0K
 
 
 
 
 
Interest Expense On Debt2.2M2.0M1.5M306.0K
 
 
 
 
 
Other Expenses-586.0K-101.0K-428.0K74.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income6.7M46.3M52.0M-9.4M
 
 
 
 
 
Income Taxes-2.1M-12.8M-18.0M-4.5M
 
 
 
 
 
Net Income4.6M33.6M33.9M-4.9M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS41.0M41.2M44.3M49.6M
 
 
 
 
 
Shares To Calculate EPS Diluted50.1M50.5M51.0M49.6M
 
 
 
 
 
 
Earnings Per ShareEPS$0.11$0.68$0.67-$0.10
 
 
 
 
 
EPS Diluted$0.11$0.68$0.67-$0.10